Literature DB >> 1360648

Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene.

M Ogura1, T Takatori, T Tsuruo.   

Abstract

We have purified a protein, NF-R1, that specifically binds to two unrelated motifs--the ATTCAGTCA motif and the GC-box motif--on the MDR1 proximal promoter. Purified NF-R1 has been confirmed by southwestern blotting to be a 110-kDa protein. Methylation interference analysis revealed that the nucleotides were in close contact with purified NF-R1 on the ATTCAGTCA and GC-box motifs. The nucleotides were required for the binding of NF-R1, as seen by competition gel mobility shift assay using point mutated oligonucleotides. In a CAT expression assay using the corresponding point-mutated MDR1 promoter fused to a CAT gene, binding inhibition of NF-R1 to the promoter resulted in 2- to 3-fold increases of CAT activity, as compared to the intact promoter in Adriamycin-resistant K562 cells. Thus NF-R1 has a relation to the negative regulation of the MDR1 gene transcription.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360648      PMCID: PMC334420          DOI: 10.1093/nar/20.21.5811

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses.

Authors:  P F Johnson; W H Landschulz; B J Graves; S L McKnight
Journal:  Genes Dev       Date:  1987-04       Impact factor: 11.361

3.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

Authors:  W T Beck; T J Mueller; L R Tanzer
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

4.  The gapped duplex DNA approach to oligonucleotide-directed mutation construction.

Authors:  W Kramer; V Drutsa; H W Jansen; B Kramer; M Pflugfelder; H J Fritz
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

5.  Contact points between a positive transcription factor and the Xenopus 5S RNA gene.

Authors:  S Sakonju; D D Brown
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter.

Authors:  I Kemler; E Schreiber; M M Müller; P Matthias; W Schaffner
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

10.  Identification and characterization of three DNA-binding proteins on the promoter of the human MDR1 gene in drug-sensitive and -resistant cells.

Authors:  M Ogura; T Takatori; Y Sugimoto; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1991-10
View more
  9 in total

1.  Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity.

Authors:  Ziyuan Wang; Long Zhang; Zhenhua Ni; Jian Sun; Hong Gao; Zhuoan Cheng; Jianhua Xu; Peihao Yin
Journal:  Tumour Biol       Date:  2015-07-01

Review 2.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 3.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.

Authors:  V Gekeler; J Beck; A Noller; A Wilisch; G Frese; M Neumann; R Handgretinger; G Ehninger; H Probst; D Niethammer
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

5.  Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.

Authors:  U Stein; W Walther; R H Shoemaker
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 6.  Transcriptional regulation of multidrug resistance in breast cancer.

Authors:  R I Glazer; C Rohlff
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Cytokine-mediated reversal of multidrug resistance.

Authors:  U Stein; W Walther
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

8.  Transcriptional regulation of MDR genes.

Authors:  K W Scotto; D A Egan
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

9.  Purification and characterization of NF-R2 that regulates the expression of the human multidrug resistance (MDR1) gene.

Authors:  T Takatori; M Ogura; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1993-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.